Journal list Promote Sponsor
verified SJR 1,145 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Journal of Diabetes Investigation
Australia · John Wiley and Sons Inc
workspace_premium Q1 — Medicine (miscellaneous) visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Journal of Diabetes Investigation

Journal of Diabetes Investigation is a journal indexed in SJR in Medicine (miscellaneous) and Endocrinology, Diabetes and Metabolism with an H index of 75. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2700 €. The scope of the journal is focused on endocrinology, life style, diabetes. It has an SJR impact factor of 1,145 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,145.

ISSN: 2040-1116
Publisher: John Wiley and Sons Inc
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,145 Q1
H-index 75
Acceptance rate pie_chart
29% Selective
Source Acceptance_Rate
Time to publication hourglass_top
25 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
2.700 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

1,145

H-index

75

Docs (year)

216

Docs 3y

711

Total refs

7747

Cites 3y

2264

Citable 3y

607

Cites/Doc 2y

2.98

Ref/Doc

35.87

Immediate OA

2700 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biomarkers of progression in diabetic nephropathy: The past, present and future

View more

Validity and reliability of a point-of-care nerve conduction device in diabetes patients

View more

Development of postpartum Graves' disease and type 1 diabetes after delivery in a patient with gestational diabetes

View more

Corneal confocal microscopy: Recent progress in the evaluation of diabetic neuropathy

View more

Comparison of efficacy of concomitant administration of mitiglinide with voglibose and double dose of mitiglinide in patients with type 2 diabetes mellitus

View more

Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure†

View more

Combined intervention for the tertiary prevention of type 1 diabetes

View more

Combined effects of physiologically relevant disturbed wall shear stress and glycated albumin on endothelial cell functions associated with inflammation, thrombosis and cytoskeletal dynamics

View more

Clinical utility of carotid ultrasonography: Application for the management of patients with diabetes

View more

Case of anal fistula with Fournier's gangrene in an obese type 2 diabetes mellitus patient

View more

Cardiorenal protective effect of sodium-glucose cotransporter 2 inhibitors and mitochondrial function

View more

Brown rice-specific gamma-oryzanol as a promising prophylactic avenue to protect against diabetes mellitus and obesity in humans

View more
SHOW MORE ARTICLES

Brave new world: Our journal has become an Open Access journal

View more

A commentary on the VITAL study: Does vitamin D (receptor activation) protect against nephropathy in type 2 diabetes?

View more

Bariatric and metabolic surgery in Asia: Where are we, and where are we going?

View more

Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy

View more

Association between the level of circulating adiponectin and prediabetes: A meta-analysis

View more

Association between insulin resistance and metabolic syndrome risk factors in Japanese

View more

Aspirin for primary prevention of cardiovascular disease in diabetes

View more

Are late-night eating habits and sleep duration associated with glycemic control in adult type 1 diabetes patients treated with insulin pumps?

View more

Anthropometric indicators of obesity for identifying cardiometabolic risk factors in a rural Bangladeshi population

View more

Altered T-cell subsets and transcription factors in latent autoimmune diabetes in adults taking sitagliptin, a dipeptidyl peptidase-4 inhibitor: A 1-year open-label randomized controlled trial

View more

Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan

View more

Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks

View more

FAQs